What is the ESG rating for MRK?

Merck & Co., Inc. has the following ESG ratings: Sustainalytics ESG Risk: 64, ESG Enterprise Score: BBB.

What are the main strengths of investing in MRK?

The main strengths of investing in Merck & Co., Inc. include: Diversified global health care company with strong research & development capabilities, Leading position in the vaccine market with blockbuster products such as Gardasil 9, A strong commitment to environmental, social, and governance (ESG) issues.

What are the potential drawbacks of investing in MRK?

Potential drawbacks of investing in Merck & Co., Inc. include: The company is highly dependent on patented drugs, which are subject to generic competition, Merck has been involved in several major litigation cases in recent years.

What are the key financial metrics for MRK?

Key financial metrics for Merck & Co., Inc. include: Market Cap: $19578.50 billion, Dividend Yield: 4.16%.

${quote.companyName} (${symbol}) Stock Analysis

Price Chart

Real-time data provided by Alpha Vantage

Financial Metrics

Market Cap

$298.2B

P/E Ratio

N/A

52-Week High

$348.22

52-Week Low

$248.22

Volume

4,866,745

Average Volume

N/A

Dividend Yield

250.00%

Beta

N/A

Key Statistics

Market Cap$298.2B

P/E Ratio (TTM)N/A

Volume4,866,745

Avg VolumeN/A

52-Week High$348.22

52-Week Low$248.22

Dividend Yield250.00%

BetaN/A

ESG Ratings

Overall ESG Score64.0/100

Environmental62.0/100

Social54.0/100

Governance63.0/100

MRK Inc.

MRK

$298.22

MRK Inc. (MRK)

Price Chart

Financial Metrics

Key Statistics

ESG Ratings